4.8 Article

Site-specific effects of neurosteroids on GABAA receptor activation and desensitization

Journal

ELIFE
Volume 9, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.55331

Keywords

-

Categories

Funding

  1. National Institutes of Health [2R01GM108799-05, 5R01GM108580-06, 5K08GM126336-03]
  2. Taylor Family Institute for Innovative Psychiatric Research

Ask authors/readers for more resources

This study examines how site-specific binding to three identified neurosteroid-binding sites in the alpha(1)beta(3) GABA(A) receptor (GABA(A)R) contributes to neurosteroid allosteric modulation. We found that the potentiating neurosteroid, allopregnanolone, but not its inhibitory 3 beta-epimer epi-allopregnanolone, binds to the canonical beta(3)(+)-alpha(1)(-) intersubunit site that mediates receptor activation by neurosteroids. In contrast, both allopregnanolone and epi-allopregnanolone bind to intrasubunit sites in the beta(3) subunit, promoting receptor desensitization and the alpha(1) subunit promoting effects that vary between neurosteroids. Two neurosteroid analogues with diazirine moieties replacing the 3-hydroxyl (KK148 and KK150) bind to all three sites, but do not potentiate GABA(A)R currents. KK148 is a desensitizing agent, whereas KK150 is devoid of allosteric activity. These compounds provide potential chemical scaffolds for neurosteroid antagonists. Collectively, these data show that differential occupancy and efficacy at three discrete neurosteroid-binding sites determine whether a neurosteroid has potentiating, inhibitory, or competitive antagonist activity on GABA(A)Rs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Common binding sites for cholesterol and neurosteroids on a pentameric ligand-gated ion channel

Melissa M. Budelier, Wayland W. L. Cheng, Zi-Wei Chen, John R. Bracamontes, Yusuke Sugasawa, Kathiresan Krishnan, Laurel Mydock-McGrane, Douglas F. Covey, Alex S. Evers

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2019)

Article Biochemistry & Molecular Biology

Multiple functional neurosteroid binding sites on GABAA receptors

Zi-Wei Chen, John R. Bracamontes, Melissa M. Budelier, Allison L. Germann, Daniel J. Shin, Krishnan Kathiresan, Ming-Xing Qian, Brad Manion, Wayland W. L. Cheng, David E. Reichert, Gustav Akk, Douglas F. Covey, Alex S. Evers

PLOS BIOLOGY (2019)

Article Nanoscience & Nanotechnology

Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation

Gyu Seong Heo, Yongfeng Zhao, Deborah Sultan, Xiaohui Zhang, Lisa Detering, Hannah P. Luehmann, Xiangyu Zhang, Richen Li, Ankur Choksi, Savannah Sharp, Sidney Levingston, Tina Primeau, David E. Reichert, Guorong Sun, Babak Razani, Shunqiang Li, Katherine N. Weilbaecher, Farrokh Dehdashti, Karen L. Wooley, Yongjian Liu

ACS APPLIED MATERIALS & INTERFACES (2019)

Article Biochemistry & Molecular Biology

The molecular determinants of neurosteroid binding in the GABA(A) receptor

Yusuke Sugasawa, John R. Bracamontes, Kathiresan Krishnan, Douglas F. Covey, David E. Reichert, Gustav Akk, Qiang Chen, Pei Tang, Alex S. Evers, Wayland W. L. Cheng

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)

Article Chemistry, Analytical

Charge Reduction of Membrane Proteins in Native Mass Spectrometry Using Alkali Metal Acetate Salts

John T. Petroff, Ailing Tong, Lawrence J. Chen, Gregory T. Dekoster, Farha Khan, Jeff Abramson, Carl Frieden, Wayland W. L. Cheng

ANALYTICAL CHEMISTRY (2020)

Article Pharmacology & Pharmacy

Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions

Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach

MOLECULAR PHARMACOLOGY (2020)

Article Pharmacology & Pharmacy

Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites

Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach, Gustav Akk

MOLECULAR PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Validation of Trifluoromethylphenyl Diazirine Cholesterol Analogues As Cholesterol Mimetics and Photolabeling Reagents

Kathiresan Krishnan, Mingxing Qian, McKenna Feltes, Zi-Wei Chen, Sarah Gale, Lei Wang, Yusuke Sugasawa, David E. Reichert, Jean E. Schaffer, Daniel S. Ory, Alex S. Evers, Douglas F. Covey

Summary: Cholesterol analogues containing aliphatic diazirine or TPD groups were used as photoaffinity labeling reagents to study cholesterol binding sites on GLIC. The probes showed differences in photolabeling efficiencies and residues identified, indicating complementary information provided by the two classes of probes. Photoaffinity labeling using these reagents in mammalian cell membranes revealed differences in the pattern of labeled proteins, highlighting their utility in future studies of cholesterol biology.

ACS CHEMICAL BIOLOGY (2021)

Article Pharmacology & Pharmacy

Intrasubunit and Intersubunit Steroid Binding Sites Independently and Additively Mediate α1β2γ2L GABAA Receptor Potentiation by the Endogenous Neurosteroid Allopregnanolone

Allison L. Germann, Spencer R. Pierce, Hiroki Tateiwa, Yusuke Sugasawa, David E. Reichert, Alex S. Evers, Joe Henry Steinbach, Gustav Akk

Summary: Previous work has identified three distinct binding sites for potentiating steroids in the heteromeric GABA(A) receptor, with mutations in these sites showing independent and additive effects. The findings suggest that mutations in sites I and II have energetically additive effects, while mutations in site III do not affect potentiation by the steroid. The results indicate that steroid actions at each binding site are independent.

MOLECULAR PHARMACOLOGY (2021)

Article Physiology

Mapping nephron mass in vivo using positron emission tomography

Edwin J. Baldelomar, David E. Reichert, Kooresh Shoghi, Scott C. Beeman, Jennifer R. Charlton, Lori Strong, Nikki Fettig, Amanda Klaas, Kevin M. Bennett

Summary: The research presented a novel contrast agent, RadioCF, for mapping functioning glomeruli in the kidney using PET technology. RadioCF-PET can accurately distinguish kidneys between healthy mice and those with low nephron mass, with potential for clinical translation.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)

No Data Available